Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CERAB - Prospective, Non-Randomised Clinical Trial to Investigate the BeGraft Aortic Stent Graft System and the BeGraft Peripheral Stent Graft System Treating Aortic-iliac Occlusive Disease With CERAB

NCT05805111 is registered in ClinicalTrials.gov with Marc Bosiers, MD as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05805111 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CERAB - Prospective, Non-Randomised Clinical Trial to Investigate the BeGraft Aortic Stent Graft System and the BeGraft Peripheral Stent Graft System Treating Aortic-iliac Occlusive Disease With CERAB
Lead sponsor
Marc Bosiers, MD
Phase
Observational
Overall status
Recruiting
Start date
April 5, 2024
Completion date
July 31, 2027
Enrollment
109 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

aorto-iliac occlusive disease